Ever since they were established to fight “foot and mouth” and “blue tongue” diseases threatening Australia’s cattle and sheep in the 1960s, CSIRO’s animal health laboratories have been at the cutting edge of infectious disease research.
In late 2012, researchers at the Australian Animal Health Laboratory (AAHL) developed a world-first vaccine for the Hendra virus.
A unique world class Biosecure Immunology Laboratory has been launched at AAHL that is set to play a key role in the continuing battle against emerging infectious diseases – with potential for developing new treatments for diseases such as influenza and the new Middle Eastern Respiratory Syndrome (MERS).
The new laboratory, within the quarantined biosecure area of AAHL is one of the world’s most sophisticated high-containment laboratories. Its high-end flow cytometry equipment, obtained as the result of a CSIRO and Deakin collaboration, will enable real-time analysis of immune response mechanisms in infected living cells.
Deakin’s Deputy Vice-Chancellor (Research) Professor Lee Astheimer congratulated the researchers from CSIRO and Deakin who obtained the funds for the project, and who are collaborating on a range of projects impacting both animal and human infectious disease. These collaborations have been core to the development of the Geelong Centre for Emerging Infectious Disease (GCEID), which is a research partnership between Deakin, CSIRO, AAHL and Barwon Health.
More details available @ Deakin Research